Biotech Losing Streak Continues (IBB)

Go back to Biotech Losing Streak Continues (IBB)

Argus Upgrades Vertex (VRTX) to Buy

September 28, 2015 8:01 AM EDT

Argus upgraded Vertex (NASDAQ: VRTX) from Hold to Buy with a price target of $126.00, saying they have been waiting for a pullback to upgrade the shares.

The analyst notes shares have declined 16% in the past week, as investors rotated out of Biotech stocks over... More